EPW
EXAS

Elevated Private Wealth’s Exact Sciences EXAS Stock Holding History

Elevated Private Wealth’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$276K Buy
+2,721
New +$219K 0.28% 74

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Elevated Private Wealth's EXAS Position: Q4 2025 in Review

Elevated Private Wealth opened a new position in Exact Sciences (EXAS) in Q4 2025: 2,721 shares worth $276K. The stake represents 0.28% of the portfolio and ranks #74 among its holdings.

710 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Elevated Private Wealth held 2,721 shares of Exact Sciences worth $276K as of Q4 2025.
  • Exact Sciences was a new Elevated Private Wealth position in Q4 2025.
  • Exact Sciences made up 0.28% of Elevated Private Wealth's portfolio in Q4 2025, its #74 holding.
  • 710 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Elevated Private Wealth's 13F filing for Q4 2025, filed 12 Feb 2026.